Suppr超能文献

日本精神活性物质和植物滥用的当前趋势调查。

Survey of current trends in the abuse of psychotropic substances and plants in Japan.

作者信息

Kikura-Hanajiri Ruri, Uchiyama Nahoko, Goda Yukihiro

机构信息

National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya, Tokyo 158-8501, Japan.

出版信息

Leg Med (Tokyo). 2011 May;13(3):109-15. doi: 10.1016/j.legalmed.2011.02.003. Epub 2011 Mar 5.

Abstract

In recent years, many analogs of narcotics have been widely distributed as easily available psychotropic substances and have become a serious problem in Japan. To counter the spread of these non-controlled substances, the Pharmaceutical Affairs Law in Japan was amended in 2006 to establish a new category, "designated substances", to more strictly control these psychotropic substances. Fifty-one substances have been listed in this category as of December 2010. However, many new analogs have appeared, one after the other. Although the distribution of tryptamine-type designer drugs has decreased since the amendment of the law, the distribution of cathinone derivatives, as well as of phenetylamine-type and piperazine-type designer drugs, has increased. Moreover, non-controlled psychotropic plants have become popular in place of chemical psychotropic substances, which are now subject to stricter controls. Additionally, since 2008, new herbal products containing synthetic cannabinoids (for example, a brand named "Spice") have appeared. Sixteen synthetic cannabinoids, classified into four groups, have been detected in products purchased up to December 2010 via Japanese-based websites. The distribution of products containing the psychoactive substances described above (so-called "legal highs" in European countries) is a worldwide problem. In this review, we survey current trends in the abuse of psychotropic substances and plants in Japan, focusing especially on synthetic cannabinoids, cathinone derivatives and psychotropic plants.

摘要

近年来,许多麻醉药品类似物作为容易获得的精神药物被广泛分销,在日本已成为一个严重问题。为应对这些非管制物质的传播,日本《药事法》于2006年修订,设立了一个新类别“指定物质”,以更严格地管制这些精神药物。截至2010年12月,该类别已列出51种物质。然而,许多新的类似物相继出现。尽管自法律修订以来色胺类设计药物的分销有所减少,但卡西酮衍生物以及苯乙胺类和哌嗪类设计药物的分销却有所增加。此外,不受管制的精神植物已取代现在受到更严格管制的化学精神药物而流行起来。此外,自2008年以来,含有合成大麻素的新草药产品(例如一个名为“Spice”的品牌)出现了。截至2010年12月,通过日本网站购买的产品中已检测到16种合成大麻素,分为四类。含有上述精神活性物质的产品(在欧洲国家被称为“合法兴奋剂”)的分销是一个全球性问题。在本综述中,我们调查了日本精神药物和植物滥用的当前趋势,尤其关注合成大麻素、卡西酮衍生物和精神植物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验